Funicular Fund LP 13D and 13G filings for ARCA biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-06-21 4:30 pm Purchase | 2022-06-15 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 215,093 17.910% | 15,320 (+7.67%) | Filing |
| 2022-05-11 4:56 pm Purchase | 2022-05-09 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 199,773 16.640% | 18,848 (+10.42%) | Filing |
| 2022-04-14 4:38 pm Purchase | 2022-04-12 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 180,925 15.060% | 18,842 (+11.63%) | Filing |
| 2022-04-04 5:10 pm Purchase | 2022-03-31 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 162,083 13.500% | 84,163 (+108.01%) | Filing |
| 2022-03-28 4:20 pm Purchase | 2022-03-18 | 13D | ARCA biopharma, Inc. ABIO | Funicular Fund LP | 77,920 6.490% | 77,920 (New Position) | Filing |